Stoke Therapeutics, Inc. ($STOK)
TZIANABOS ARTHUR โ Director
Shares
3,955
Price
$8.33
Total Value
$32,945.15
Nearby Earnings
Mar 17, 2026
EPS:-0.99 (est: -0.92)+8.1%
Revenue:$1.40M (est: $6.24M)-77.5%
Transaction Details
| Insider | TZIANABOS ARTHUR |
|---|---|
| Title | Director |
| Transaction Date | Mar 10, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 12, 2026 |
| Shares Purchased | 3,955 |
| Price per Share | $8.33 |
| Total Value | $32,945.15 |
| Shares Owned After | 35,694 |
| Derivative | No |
| Accession Number | 0001586226-26-000002 |
| Document | View SEC Filing |